Immune status of HIV and HCV negative haemophiliacs treated with intermediate-purity factor VIII concentrates.
Funk
M
M
Ebener
U
U
Kreuz
W
W
Ehrenforth
S
S
D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005169:Factor VIII / Q000627:therapeutic use*; D018023:HIV Seronegativity; D006467:Hemophilia A / Q000276:immunology* / Q000382:microbiology / Q000628:therapy; D016174:Hepacivirus / Q000276:immunology; D006508:Hepatitis Antibodies / Q000032:analysis*; D018937:Hepatitis C Antibodies; D006801:Humans; D007136:Immunoglobulins / Q000032:analysis; D016131:Lymphocyte Subsets; D014842:von Willebrand Diseases / Q000276:immunology* / Q000382:microbiology / Q000628:therapy
D006508:Hepatitis Antibodies; D018937:Hepatitis C Antibodies; D007136:Immunoglobulins; D005169:Factor VIII